Carel W le Roux Selected Research

Weight Loss (Weight Reduction)

12/2022	Mechanisms of Weight Loss After Obesity Surgery.
7/2022	The relationship between early weight loss and weight loss maintenance with naltrexone-bupropion therapy.
5/2022	The Impact Once-Weekly Semaglutide 2.4 mg Will Have on Clinical Practice: A Focus on the STEP Trials.
3/2022	Pharmacological profile of once-weekly injectable semaglutide for chronic weight management.
1/2022	The Relationship Between Percentage Weight Loss and World Health Organization-Five Wellbeing Index (WHO-5) in Patients Having Bariatric Surgery.
1/2022	Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation.
12/2021	Amylin as a Future Obesity Treatment.
12/2021	Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial.
11/2021	"You Are Always at War With Yourself" The Perceptions and Beliefs of People With Obesity Regarding Obesity as a Disease.
8/2021	Weight loss with bariatric surgery or behaviour modification and the impact on female obesity-related urine incontinence: A comprehensive systematic review and meta-analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carel W le Roux Research Topics

Disease

102	Weight Loss (Weight Reduction) 12/2022 - 01/2006
81	Obesity 10/2022 - 01/2006
60	Type 2 Diabetes Mellitus (MODY) 03/2022 - 12/2010
29	Body Weight (Weight, Body) 05/2022 - 01/2006
17	Morbid Obesity 01/2021 - 09/2009
14	Insulin Resistance 10/2022 - 12/2010
12	Diabetic Nephropathies (Diabetic Nephropathy) 02/2022 - 09/2014
12	Inflammation (Inflammations) 01/2022 - 05/2010
9	Albuminuria 02/2022 - 11/2014
9	Neoplasms (Cancer) 02/2021 - 01/2011
8	Chronic Renal Insufficiency 12/2020 - 01/2018
6	Overweight 10/2022 - 10/2012
6	Nausea 12/2021 - 08/2006
6	Hypertension (High Blood Pressure) 12/2020 - 09/2009
5	Diabetes Mellitus 05/2022 - 02/2013
4	Kidney Diseases (Kidney Disease) 01/2021 - 11/2013
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2011
3	Prediabetic State (Prediabetes) 10/2022 - 01/2017
3	Non-alcoholic Fatty Liver Disease 07/2022 - 10/2018
3	Fibrosis (Cirrhosis) 07/2022 - 01/2020
3	Diabetes Complications 01/2021 - 09/2014
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 01/2020
3	Hypertrophy 07/2010 - 09/2007
2	Alcoholic Fatty Liver 07/2022 - 01/2022
2	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 01/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2016
2	Proteinuria 12/2020 - 07/2013
2	Necrosis 01/2020 - 01/2018
2	Infections 11/2019 - 03/2014
2	Cachexia 06/2019 - 12/2016
2	Dumping Syndrome (Syndrome, Dumping) 07/2017 - 06/2014
2	Glucose Intolerance 01/2017 - 09/2012
2	Diarrhea 07/2015 - 11/2009
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2015 - 02/2013
2	Metabolic Diseases (Metabolic Disease) 03/2013 - 02/2013
1	Hepatitis 07/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2022

Drug/Important Bio-Agent (IBA)

29	Hormones (Hormone)IBA 02/2021 - 01/2006
25	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 07/2012
16	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2022 - 09/2007
16	Insulin (Novolin)FDA Link 01/2022 - 12/2010
11	salicylhydroxamic acid (SHAM)IBA 12/2020 - 05/2010
10	Liraglutide FDA Link 12/2021 - 02/2015
10	Peptides (Polypeptides)IBA 01/2021 - 05/2008
10	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 11/2009
8	Biomarkers (Surrogate Marker)IBA 07/2022 - 09/2011
8	Peptide YYIBA 03/2016 - 08/2006
6	GhrelinIBA 01/2021 - 08/2006
5	semaglutideIBA 10/2022 - 11/2019
5	LeptinIBA 01/2022 - 03/2011
5	Blood Glucose (Blood Sugar)IBA 01/2021 - 02/2015
5	LipidsIBA 01/2021 - 02/2013
5	Glucagon (Glukagon)FDA Link 01/2021 - 09/2012
5	CreatinineIBA 01/2020 - 06/2017
4	Glucagon-Like Peptide-1 ReceptorIBA 03/2022 - 01/2018
4	Triglycerides (Triacylglycerol)IBA 02/2022 - 04/2015
4	AlbuminsIBA 01/2020 - 06/2017
3	HDL CholesterolIBA 07/2022 - 01/2021
3	C-Reactive ProteinIBA 01/2022 - 01/2018
3	CholesterolIBA 01/2021 - 09/2017
3	GlicentinIBA 01/2021 - 01/2020
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 05/2014
3	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 01/2020 - 05/2008
3	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 02/2015
3	CytokinesIBA 01/2016 - 05/2012
2	Pharmaceutical PreparationsIBA 03/2022 - 08/2017
2	Biological ProductsIBA 11/2021 - 01/2020
2	MicronutrientsIBA 02/2021 - 01/2019
2	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 01/2021 - 08/2009
2	Phenobarbital (Luminal)FDA Link 12/2020 - 01/2011
2	CanagliflozinIBA 01/2020 - 11/2019
2	Proteins (Proteins, Gene)FDA Link 12/2018 - 01/2017
2	Peptide Hormones (Polypeptide Hormones)IBA 01/2018 - 01/2015
2	IncretinsIBA 08/2017 - 03/2014
2	CarbohydratesIBA 07/2017 - 07/2012
2	Calcium Gluconate (CBG)IBA 03/2010 - 11/2009
2	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2010 - 11/2009
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2022
1	Bupropion (Wellbutrin)FDA LinkGeneric 07/2022
1	Naltrexone (ReVia)FDA LinkGeneric 07/2022
1	Pemetrexed (MTA)FDA Link 02/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022
1	Ciliary Neurotrophic Factor (CNTF)IBA 01/2022
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 12/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2021
1	pramlintide (Symlin)FDA Link 12/2021

Therapy/Procedure

102	Bariatric Surgery 12/2022 - 01/2006
64	Gastric Bypass (Roux-en-Y Gastric Bypass) 02/2022 - 11/2007
26	Therapeutics 07/2022 - 01/2009
15	Gastrectomy 10/2021 - 07/2013
11	Glycemic Control 12/2020 - 01/2006
6	Drug Therapy (Chemotherapy) 05/2022 - 05/2014
5	Biliopancreatic Diversion 01/2018 - 09/2007
3	Esophagectomy 01/2021 - 01/2019
2	Length of Stay 01/2021 - 03/2014
2	Combined Modality Therapy 01/2019 - 09/2015
2	Operative Surgical Procedures 08/2017 - 07/2013
1	Nutritional Support (Artificial Feeding) 05/2022
1	Injections 03/2022
1	Obesity Management 01/2022